Peer Review History
| Original SubmissionDecember 14, 2021 |
|---|
|
PONE-D-21-39441Commitment to protective measures during COVID-19 pandemic in Syria: a nationwide cross-sectional study.PLOS ONE Dear Dr. Shibani, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Feb 20 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Sanjay Kumar Singh Patel, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this paper entitled "Commitment to protective measures during COVID-19 pandemic in Syria: a nationwide cross-sectional study", the authors evaluate the extent to which the Syrian population adheres to these measures and analyze the relationship between demographic variables and adherence. The manuscript is well written and intelligently presented. The study is nicely designed, and the sample size is calculated using OpenEpi online software. All the data is analyzed using Statistical Package for Social Sciences version 25.0. The results are presented in a tabular form that gives a complete overview of the data collected. In addition, percentage, correlation and p-value are calculated to provide statistical stringency to the manuscript. I congratulate the authors for this work and recommend this work for publication. The manuscript is suitable for publications and should be formally accepted once it meets all technical requirements. Although it has one or two typos in the manuscript (lines 229,230),it needs to provide high-resolution fig 1 or remove it from the manuscript. Reviewer #2: The manuscript entitled “Commitment to protective measures during COVID-19 pandemic in Syria: a nationwide cross-sectional study.” written by Shibani et al investigated the extent to which the Syrian population adheres to precautionary infection control measures and analyze the relationship between demographic variables and adherence. Authors did a cross-sectional study in Syria between January 17 and March 17, 2021 using a structured self-administered questionnaire. Authors concluded that this study generally showed a high level of adherence to the preventive measures compared to participants in other studies from around the world, with some concerns regarding risk perception and the sources of information they depend on. This manuscript requires minor revision prior to its publication in PLOS One as follows: Suggestions: - 1. The background section can be updated with minor information such as health, diet and immunity, the natural COVID-19 preventive measures and various variants of COVID-19 i.e. doi: 10.1007/s12088-020-00893-4; doi: 10.1007/s12088-020-00908-0; doi: 10.1007/s15010-021-01734-2. 2. Figures quality may be improved with high resolution images (minor). 3. It would be required to provide one illustrative Figure as to highlight the summary or future prospect of this study. 4. Did authors ask about vaccination status in their survey (vaccinated/not vaccinated/will receive vaccination/reluctant for vaccination? 5. The English of manuscript can be polished (minor). 6. The authors should cross-check all abbreviations in the manuscript. Initially, define in full name followed by abbreviation. Reviewer #3: This study investigated the commitment status of Syrian population to the protective measures against SARS-CoV-2 viral infection during COVID-19 pandemic. The manuscript is well organized and worth to be published. Yet, given the high contagious nature of the SARS-CoV-2 virus, commitment to the protective measures may only help to delay the infection to some limited extent, and eventually all members of the public will get infected by the virus in the long time. So, the paper will be more attractive if the authors can also provide some insightful understanding about infectious diseases like the SARS-CoV-2 infection, so that the public know what to do to avoid to develop into severe case of COVID-19 if they are infected by SARS-CoV-2 virus. In talking about infectious diseases, it would be better if we distinguish infections from diseases. Infection is the presence of pathogen, which is not a sufficient condition for disease. [1] Like most of the other viral and bacterial infections, the SARS-COV-2 viral infection is self-limiting [2]. When the human cells are infected by virus or bacteria, the human immunity will actively induce cell self-destruction (programmed cell deaths like necroptosis [3] and pyroptosis [4]) to stop the intracellular infection and reuse the nutrition from the degradation of these destroyed cells and the microorganisms in these cells to rebuild the tissue cells [5]. So by actively destroy damaged somatic cells, the viral and bacterial infections are also removed and become self-limiting [6]. Therefore most of the COVID-19 cases are asymptomatic or very mild. Most of the severe cases of infectious diseases are the result of the overreaction of the strong yet malfunctioning immune system, as Sir William Osler stated more than 100 years ago: "Except on few occasions, the patient appears to die from the body’s response to infection rather than from it. Sir William Osler (1904)" [7]. As the human immune system also plays a virtual role in nutrition acquisition from the degradation of viral damaged epithelial cells, the nutrition surge coupled with the overnutrition state in some patients with obesity or metabolic syndromes may contribute to lipotoxicity and damage in non-adipose tissues, triggering hyperinflammation and contribute to the malfunction of the immune system. So the SARS-CoV-2 viral infection is only the trigger for the COVID-19 disease, and the real cause for the severe cases of COVID-19 disease are autoimmune disorder [8] caused by overnutrition which leads to the hyperinflammation and cytokine storm in these patients. References: 1. V Humphries DL, Scott ME, Vermund SH (2021) Pathways linking nutritional status and infectious disease: causal and conceptual frameworks. In: Nutrition and infectious diseases, Shifting the Clinical Paradigm (eds DL Humphries, ME Scott, SH Vermund), pp. 3–22. Cham, Switzerland: Humana. DOI: 10.1007/978-3-030-56913-6_1 2. Kumar S, Veldhuis A, Malhotra T (2021) Neuropsychiatric and Cognitive Sequelae of COVID-19. Front Psychol 12:577529. DOI: 10.3389/fpsyg.2021.577529. 3. Nailwal, H., Chan, F.KM. Necroptosis in anti-viral inflammation. Cell Death Differ 26, 4–13 (2019). DOI: 10.1038/s41418-018-0172-x 4. Jorgensen I, Miao EA (2015) Pyroptotic cell death defends against intracellular pathogens. Immunological Reviews. 265 (1): 130-142. DOI:10.1111/imr.12287 5. Maitre Y, Mahalli R, Micheneau P, Delpierre A, Amador G, Denis F (2021) Evidence and Therapeutic Perspectives in the Relationship between the Oral Microbiome and Alzheimer's Disease: A Systematic Review. Int J Environ Res Public Health 18(21):11157. DOI: 10.3390/ijerph182111157. 6. Levin BR, Baquero F, Ankomah P, McCall IC (2017) Phagocytes, Antibiotics, and Self-Limiting Bacterial Infections. Trends in Microbiology, 25(11):878-892. DOI: 10.1016/j.tim.2017.07.005 7. Dobson GP, Biros E, Letson HL and Morris JL (2021) Living in a Hostile World: Inflammation, New Drug Development, and Coronavirus. Front. Immunol. 11:610131. DOI: 10.3389/fimmu.2020.610131 8. Halpert G, Yehuda Shoenfeld Y (2020) SARS-CoV-2, the autoimmune virus. Autoimmunity Reviews 19(12):102695. DOI: 10.1016/j.autrev.2020.102695. ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-39441R1Commitment to protective measures during COVID-19 pandemic in Syria: a nationwide cross-sectional study.PLOS ONE Dear Dr. Shibani, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please address issues raised by the AE and reviewers as suggested in comments for the authors. Please submit your revised manuscript by Jul 21 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Syed Ghulam Sarwar Shah, M.B.B.S., M.A., M.Sc., Ph.D. Academic Editor PLOS ONE Additional Editor Comments: Thanks for your revised manuscript, which is has following issues that need to be addressed. Title: Please add ‘the’ before COVID-19 pandemic. Abstract: 1. Please report the sample size and sample type in the methods section of abstract. 2. Please report the total number of respondents and the response rate in the results section. 3. Please revise this sentence as it is not clear “Statistically significant differences across age, sex, marital status, financial status, employment, and educational attainment when correlated against commitment to preventive measures.” 4. Please reconcile your statements about adherence to preventive measures in the abstract because in the results section you report ‘good adherence ‘while in the conclusion section you state ‘high level of adherence’. Good and High level are not same thing. Moreover, you have reported ‘Low’, ‘Moderate’ and ‘High’ categories of commitment in the methods section (lines 155-156). Therefore, please be consistent and report the level of commitment that was found. Backgrounds: 1. Could you please report the date on which there were ‘…over 250 million cases and over 5 million deaths (1)’. 2. Please refer to your statement about the possible impact of nutrition and immunity reported in lines 67-76. This information is not relevant because your study is about the commitment and adherence to the preventive measures and nutrition is not one of the measures. Could you please remove this text along with the references cited in this paragraph? 3. Please change ‘6pm-to-6am’to ‘6 pm-to-6 am’ (line 79). 4. Could you please change ‘wearing masks’ to ‘wearing face masks’ (line 83). 5. Could you please report the exact date instead of writing: ‘As of this writing’ in the following sentence ‘As of this writing, 45,468 laboratory-confirmed cases and 2,637 casualties.. (Line 88). METHODS: 6. Study design, setting, and participants: Please report your total sample size (how many people were invited /approached to complete the survey questionnaire) because there are different numbers reported in the manuscript. For example, in the abstract sample size is ‘10083’ reached out’ while in the methods section you report calculated sample size = 7336 and then you report 8083 people completed the survey and thereafter ‘final sample size of 7,531 participants. Please clearly report your calculated sample size as well as how many people were invited/reached out (if there is difference between these then give reasons for it). Then how many responses were received and how many cases were excluded and final sample size / responses that were analysed. In the abstract you report your final sample size included in the analysis as well as effective response rate. 7. Could you please provide more information about how your sample was ‘nationally representative sample’? (Line 110). 8. You report ‘Chain-referral and convenience sampling methods were employed...’. These might include ‘snowball sampling’? If so, please report it here as well as in the abstract. 9. Please refer to you statement: ‘The questionnaire, based on a previous study,..’ (Line 110). Could you please provide a reference/cite this study that used this questionnaire originally? 10. Could you please report in the methods section how financial status was categorised because Table 5 includes categories of the financial status of the participants. 11. Statistical analysis: Could you please add the abbreviation of names of the researchers who manually entered data in the following sentence: ‘Data from the hard copy questionnaires were entered manually by the investigators (AB, XY, etc) (lines 149-150). 12. ‘A 13 point scale was used to measure the level of commitment (Line 152) was this scale created by the authors of this study or it was already reported in the original questionnaire adopted from earlier studies (which ones?). 13. Please report the lowest and highest scores in the 13-point scale. 14. Ethics & Consent: The authors report that ‘Informed consent was obtained from every participant…’ (line 164). Could you please report how consent from participants was obtained and in which form it was obtained? RESULTS: 15. Participant characteristics: The authors report that ‘Of 10083 participants, 7531 agreed to participate,’ (Line 170) whereas in the methods section they report that 8083 people completed the survey (Line 123). Please report the actual number of participants who completed the survey and then how many surveys were fully completed. You might like to say: ‘Of 8083 retuned surveys, 7531 surveys were fully completed and analysed’. Then you can report your affective response rate. 16. Participant characteristics: Please avoid reporting same information in the text as well as in Tables. For example: ‘…3505 (46.5%) were males and 4026 (53.5%) were females. 172 The dominant age group was 18-24 years old: 3124 (41.5%), followed by 25 - 44 years old: 2338 173 (31%), 45-65 years old: 1686 (22.4%), and > 65 years: 383 (5.1%).’ (Lines 171-173. Here your repot counts and % of items/variables that are also given in Table 1. Report only the main / major findings in the text and refer to table for numbers and %. For example: Most of the respondents were women and the dominant age group was 18-24 years (Table 1). 17. Please revise this sentence: Over the half of the study population originated from the central governorates: 4376 (58.1%), and 1165 (15.5%) from the western governorates. (Lines 174-175). You might like to report as: Just more than half of the respondents originated from the central governorates while the lowest respondents were from the western governorates. 18. Please revise the text reported in lines 176-181 as suggested above. 19. Please revise the text about the findings about ‘COVID-19 related information’ and ‘Commitment to preventive measures’ as suggested in comments 15-16 above. 20. Please revise ‘…showed poor commitment. (Table 3).’ As ‘...showed low commitment. (Table 3).’ (Line 201). 21. Table 3: In this table commitment levels are reported as ‘Bad, Moderate, and Good’, whereas in the methods section commitment levels reported are: ‘Low’, ‘Moderate’ and ‘High’ (lines 155-156). Please be consistent and report the level of commitment as reported in the methods section. 22. Table 4, Please start each statement with a capital letter i.e. wearing as Wearing, cancelled as Cancelled and so on in this Table. 23. P-values: Please report p-values as <0.001 for all values 0.000 or <0.0001 in the section about ‘Correlations between commitment to preventive measures and participants characteristics’ (lines 212-233), Table 5, Table 6 and elsewhere. 24. Table 5 & Table 6: Please revise ‘Bad’ to ‘Low’ in column ‘Level of commitment’ in these tables and elsewhere. DISCUSSION 25. Please remove the text in the first paragraph in lines 240-248 “In talking about infectious diseases,…………. also removed and become self-limiting (28).” This information is about issues that are different from the focus of this study which is about the commitment to preventive measures to prevent the spread of COVID-19. Please remove all references (23-27) cited in this para. 26. The authors argue that ‘This level of adherence is similar to that found in a Belgian study’; however, comparison between Belgium and Syria does not seem to be reasonable because the two countries are very different in many aspects social, economic and so on. The authors might like to revise this argument. Similarly in the following sentence the authors compare their findings with the UK and Germany also. The authors should compare their findings with the countries in their region and with similar socio-economic situation. 27. Please change ‘The majority of our sample were young...’ (Line 261) to ‘The majority of our participants were young…’ 28. The authors report that ‘Low income and unemployment were correlated with lower adherence to IPC measures, while higher income and gainful employment was correlated with higher adherence’ (Lines 273-274). Table 5 shows similar findings about the low education level and vice versa. The authors could include the findings about the education level in this sentence. These findings are important from the policy perspective and could be included/highlighted in the conclusion. CONCLUSIONS 29. Conclusion reported in the abstract and in the main manuscript should convey the same message so please revise your conclusion at both places. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In this paper, the authors evaluate how the Syrian population adheres to these measures and analyze the relationship between demographic variables and adherence. The manuscript is well written and intelligently presented. In addition, the study is nicely designed. I congratulate the authors on this work. The manuscript is suitable for publication. Reviewer #2: This manuscript entitled "Commitment to protective measures during COVID-19 pandemic in Syria: a nationwide cross-sectional study" has improved. Reviewer #3: As the authors have addressed all my concerns in my previous review comments, the manuscript can be accepted for publication in its present form. Reviewer #4: Thank you for the opportunity to review this manuscript. It is an interesting and very well written and structured work that looks at public compliance with preventive measures in Syria during the COVID-19 pandemic. The results are interesting and informative. I think that the authors have successfully addressed the concerns and provided an important addition to the literature. My only suggestion would be to maybe add absolute as well as relative frequencies to Figure 1 to more easily identify the distribution based on sample size. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Vinay Kumar Reviewer #3: Yes: Ligen Yu Reviewer #4: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-21-39441R2Commitment to protective measures during the COVID-19 pandemic in Syria: a nationwide cross-sectional study.PLOS ONE Dear Dr. Shibani, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 18 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Syed Ghulam Sarwar Shah, M.B.B.S., M.A., M.Sc., Ph.D. Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Comments from the Academic Editor: Many thanks for addressing issues raised by AE. However, there are still few issues that need to be addressed as suggested below. 1. Authorship: A new author named ‘Dana Alakhrass’ with affiliation no. 6 has been added in this version of the manuscript. This person was not a author in the original and revised submission R1. This person could not be added as an author at this stage. If this person helped in the latest revision of the manuscript, then their name could be reported in the acknowledgments. Please refer to the PLOS ONE Guidelines for the authorship for further guidance on the issue. 2. Abstract; Conclusion- Please change 'a nationwide awareness campaigns ' to either 'A nationwide awareness campaign' or 'Nationwide awareness campaigns' in the conclusion in the abstract. 3. Background: Lines 58-59. Please correct the following sentence 'to the date of writing in December 2021'. It could be ‘as of XX December 2021' (put a particular date instead of to the date of writing). 4. Methods: Lines 115-116, Please change from 'based on a previous studies' to 'based on previous studies' 5. Financial status in Table 1 and other text: Please change financial status category of 'bad' to 'low', which reads better. Make this change in all places where you have reported 'bad' financial status. 6. Table 4: Specific preventive measures: Some of these statements start with a past tense while other use different tense. Could you please correct these statements so that they are in the same tense? All these statements should start with a capital letter. 7. Table 4: What do you mean by the amount in the following sentence 'Reduce the amount you go to shops'? Is it the 'time' or 'number of times' or something else? Please change accordingly. 8. Legends of figures and table captions: Please put full stop after the number. Change from Table .1 to Table 1. Please do the same for all figures and tables. 9. References: please update your references and include the vol. issue and page numbers as well as DOI for all journal articles and URLs for internet / website sources. In some reference year is written twice, please report it only once. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Commitment to protective measures during the COVID-19 pandemic in Syria: a nationwide cross-sectional study. PONE-D-21-39441R3 Dear Dr. Shibani, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Syed Ghulam Sarwar Shah, M.B.B.S., M.A., M.Sc., Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Thank you for addressing all issues raised by the AE and reviewers in your revised manuscript. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-39441R3 Commitment to protective measures during the COVID-19 pandemic in Syria: a nationwide cross-sectional study. Dear Dr. Shibani: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Syed Ghulam Sarwar Shah Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .